Related Experiment Videos

Noninvasive perfusion imaging of human brain tumors with EPISTAR

J Gaa1, S Warach, P Wen

  • 1Department of Radiology, Beth Israel Hospital, Boston, MA 02215, USA.

European Radiology
|January 1, 1996
PubMed

Insights

EPISTAR MR imaging can assess tumor vascularity without contrast agents. This technique showed varying signal intensities across different brain tumor types, aiding in qualitative assessment.

Area of Science:

  • Neuroradiology
  • Neuro-oncology
  • Medical Imaging

Background:

  • Brain tumors require accurate vascularity assessment for diagnosis and treatment planning.
  • Conventional methods for assessing tumor vascularity may involve contrast agents or specialized imaging techniques.

Purpose of the Study:

  • To evaluate the utility of EPISTAR (Echo-Planar Imaging in Spin-Transfer Angiography) MR imaging for qualitative assessment of brain tumor vascularity.
  • To compare EPISTAR imaging findings with tumor histology and SPECT findings.

Main Methods:

  • Seventeen patients with histologically confirmed brain tumors (astrocytoma, lymphoma, meningioma) underwent EPISTAR MR imaging.
  • Tumor-to-white matter contrast and signal heterogeneity were analyzed.
  • Comparison with SPECT (Single-Photon Emission Computed Tomography) data was performed in a subset of patients.

Main Results:

  • Meningiomas exhibited the highest EPISTAR tumor/white matter contrast, while low-grade astrocytomas and lymphomas showed the lowest.
  • High-grade astrocytomas displayed elevated and heterogeneous EPISTAR signals.
  • EPISTAR imaging demonstrated agreement with SPECT in assessing tumor vascularity.

Conclusions:

  • EPISTAR MR imaging provides a valuable method for qualitative assessment of brain tumor vascularity without requiring contrast agents.
  • The technique differentiates between tumor types based on signal characteristics and contrast ratios.
  • EPISTAR imaging holds potential as a non-invasive tool in neuro-oncology.

Related Concept Videos